Opinion 25 Jul 2022 How to improve patient recruitment in your precision medicine research Precision medicine research relies on genetic testing at scale, but has long suffered recruitment and retention headaches. The answer, says Patrick Short, CEO of Sano Genetics, is to start early and engage participants deeply. I witnessed first-hand the power of national scale genomics research through my PhD work analyzing genome sequence data from more than […] July 25, 2022 - 7 minutesmins - By External Contributor Share WhatsApp Twitter Linkedin Email
Inside Labiotech 20 Jul 2022 Connecting the R&D ecosystem: 150 days into the integration of Inova, IN-PART and Labiotech Hear from the leadership teams at Inova, IN-PART and Labiotech about how the integration of the three companies is taking shape and the impacts it will have on the R&D ecosystem. The acquisition of IN-PART and Labiotech by Inova in January signaled the intent and ambition to combine the efforts of three companies focused on […] July 20, 2022 - 5 minutesmins - By External Contributor Share WhatsApp Twitter Linkedin Email
More News! 19 Jul 2022 Bayer Consumer Health launches microbiome research call to find new academic partners Campaign launch date: Monday, July 18, 2022. Bayer Consumer Health has launched a call through IN-PART’s Discover platform to find and partner with academic experts and research groups working on microbiome-targeting solutions for upper respiratory illnesses, nutrition and digestive health as well as topical delivery through the skin. The campaign aims to accelerate Bayer’s “Partnering […] July 19, 2022 - 3 minutesmins - By External Contributor Share WhatsApp Twitter Linkedin Email
Opinion 11 Jul 2022 Precision medicine: the next big leap for metabolic disorders Chronic metabolic disorders like type 2 diabetes and cardiovascular disease are a huge burden on healthcare systems, and their treatment is often fragmented and reliant on trial-and-error approaches. Rebecca Cripps and Robert Thong at MultiOmic Health explain how precision medicine is set to change the way we think about these disorders. Metabolic disorders constitute the […] July 11, 2022 - 6 minutesmins - By External Contributor Share WhatsApp Twitter Linkedin Email
Inside Labiotech 21 Jun 2022 How you can get involved in helping the industry–academia community solve global challenges IN-PART’s ‘Global Challenge’ campaigns were born out of the response to COVID-19 in March 2020. As the impacts of the pandemic began to take hold, IN-PART recognized its position at the interface of industry and academia and its responsibility to leverage its networks to generate solutions to the unfolding crisis. Through online matchmaking platforms, IN-PART […] June 21, 2022 - 3 minutesmins - By External Contributor Share WhatsApp Twitter Linkedin Email
Opinion 16 May 2022 CRISPR Can Help The Switch To Sustainable Cosmetics The cosmetics industry is looking for greener ingredients as consumers demand more sustainable products. According to Jon Kratochvil at ERS Genomics, which licenses out patents belonging to the gene editing pioneers Emmanuelle Charpentier and Jennifer Doudna, CRISPR-Cas9 could one day meet the demand for alternatives. The global cosmetics industry is worth more than €480B ($500B), […] May 16, 2022 - 5 minutesmins - By External Contributor Share WhatsApp Twitter Linkedin Email
Opinion 25 Apr 2022 Cloud Computing Can Help Life Sciences Catch Up Before It’s Too Late Biotechnology has the power to tackle global threats such as pandemics and climate change, but antiquated experimental and data collection methods are holding it back. Guy Levy-Yurista, CEO of the experiment platform developer Synthace, explains how cloud computing could accelerate the efforts of biotech companies to solve the big problems. There is a sundial in […] April 25, 2022 - 5 minutesmins - By External Contributor Share WhatsApp Twitter Linkedin Email
Interview 10 Jan 2022 Leveraging Physics and Quantum Computing to Accelerate Drug Discovery Novel computational techniques are revolutionizing the way we discover new drugs. Robert Marino, CEO and co-founder of Qubit Pharmaceuticals, discusses the potential of physics to accelerate drug discovery. Paris-based Qubit Pharmaceuticals was established in 2020 to commercialize the work of leading researchers in the computational chemistry space. This field uses computer modeling to predict how […] January 10, 2022 - 9 minutesmins - By External Contributor Share WhatsApp Twitter Linkedin Email
Opinion 3 Jan 2022 Distributed Manufacturing of Cell Therapies Poses a Threat to Big Pharma As medical institutions develop the infrastructure for decentralized manufacturing of cell therapies, they are positioned to outperform big pharma’s limited success with a centralized approach to manufacturing. A revolution is coming in the discovery, development and delivery of living medicines. This revolution is being led by well-funded, elite academic medical centers, such as the University […] January 3, 2022 - 5 minutesmins - By External Contributor Share WhatsApp Twitter Linkedin Email
In Depth 7 Dec 2021 Is Cloud Computing the Answer to Genomics’ Big Data Problem? The success of the genomics industry has led to the generation of huge amounts of DNA sequencing data. Cloud computing could offer a solution for scientists who currently lack the tools to make full use of this data. Over the last decade, genomics has become the backbone of drug discovery. It has allowed scientists to […] December 7, 2021 - 8 minutesmins - By External Contributor Share WhatsApp Twitter Linkedin Email
Infographics by Merck 15 Nov 2021 Gene therapy: Making Rare Disease Therapies Less Rare While individually uncommon, rare diseases collectively impact the lives of over 300 million people worldwide. Many rare conditions are chronic, progressive, and life-threatening with limited treatment options available. Advances in gene therapy provide hope to actual cures and could revolutionize treatment prospects for patients with rare genetic diseases. This infographic shows how we can unlock […] November 15, 2021 - 2 minutesmins - By External Contributor Share WhatsApp Twitter Linkedin Email
Opinion 10 Nov 2021 Automation Can Solve Diversity Issues in Clinical Trial Recruitment How can we make clinical trial recruitment more reflective of the real world? Technology is coming to the rescue. The quest for diversity in clinical trials goes to the heart of patient care. Why are some demographic groups over-represented in studies when others are more difficult to recruit? Studies that fail to reflect patient demographics […] November 10, 2021 - 6 minutesmins - By External Contributor Share WhatsApp Twitter Linkedin Email